BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2219285)

  • 21. Bone marrow transplantation in children using "HLA-partially-matched" family donors.
    Martinetti M; Locatelli F; Pizzochero C; Prete L; Ambroselli F; Giani S; Comoli P; Salvaneschi L
    Bone Marrow Transplant; 1993; 11 Suppl 1():93-4. PubMed ID: 8448562
    [No Abstract]   [Full Text] [Related]  

  • 22. [Platelet function after allogeneic bone marrow transplantation in Wiskott-Aldrich syndrome].
    Megido M; Cesar JM; Maldonado MS; Otheo E; Muñoz A; Navarro JL
    Sangre (Barc); 1993 Jun; 38(3):233-4. PubMed ID: 8211550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unrelated bone marrow transplantation in a Wiskott-Aldrich syndrome patient sharing two HLA-extended haplotypes with the donor.
    La Nasa G; Pizzati A; Ledda A; Vacca A; Arras M; Contu L
    Haematologica; 1996; 81(2):178-81. PubMed ID: 8641653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term survival after bone marrow transplantation: a 15-year follow-up report of a patient with Wiskott-Aldrich syndrome.
    Meuwissen HJ; Bortin MM; Bach FH; Porter IH; Schreinmachers D; Harrison BA; Taft E
    J Pediatr; 1984 Sep; 105(3):365-9. PubMed ID: 6381679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation.
    Ozsahin H; Cavazzana-Calvo M; Notarangelo LD; Schulz A; Thrasher AJ; Mazzolari E; Slatter MA; Le Deist F; Blanche S; Veys P; Fasth A; Bredius R; Sedlacek P; Wulffraat N; Ortega J; Heilmann C; O'Meara A; Wachowiak J; Kalwak K; Matthes-Martin S; Gungor T; Ikinciogullari A; Landais P; Cant AJ; Friedrich W; Fischer A
    Blood; 2008 Jan; 111(1):439-45. PubMed ID: 17901250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of Life of Patients with Wiskott Aldrich Syndrome and X-Linked Thrombocytopenia: a Study of the Primary Immune Deficiency Consortium (PIDTC), Immune Deficiency Foundation, and the Wiskott-Aldrich Foundation.
    Shah AJ; Sokolic R; Logan B; Yin Z; Iyengar S; Scalchunes C; Mangurian C; Albert M; Cowan MJ
    J Clin Immunol; 2019 Nov; 39(8):786-794. PubMed ID: 31620947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe osteopenia with recurrent fractures after bone marrow transplant for Wiskott-Aldrich syndrome: a case report.
    Talkhani IS; Reidy D; Fogarty EE; O'Meara A
    J Pediatr Orthop; 2000; 20(3):402-4. PubMed ID: 10823614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early transplantation of unrelated cord blood in a two-month-old infant with Wiskott-Aldrich syndrome.
    Jaing TH; Tsai BY; Chen SH; Lee WI; Chang KW; Chu SM
    Pediatr Transplant; 2007 Aug; 11(5):557-9. PubMed ID: 17631028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results and long-term outcome in 39 patients with Wiskott-Aldrich syndrome transplanted from HLA-matched and -mismatched donors.
    Friedrich W; Schütz C; Schulz A; Benninghoff U; Hönig M
    Immunol Res; 2009; 44(1-3):18-24. PubMed ID: 18846321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total body irradiation and bone marrow transplantation for immunodeficiency disorders in young children.
    Halberg FE; Wara WM; Weaver KE; Wara DW; Ablin AR; Matthay KK; Mentzer WC; O'Leary MC; Cowan MJ
    Radiother Oncol; 1990; 18 Suppl 1():114-7. PubMed ID: 2247633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful bone marrow transplantation in a Chinese boy with Wiskott-Aldrich syndrome.
    Huang MT; Chou CC; Jou ST; Lin KH; Hsieh KH
    Asian Pac J Allergy Immunol; 1996 Jun; 14(1):57-63. PubMed ID: 8980801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pneumatosis intestinalis in an infant undergoing bone marrow transplantation for Wiskott-Aldrich syndrome.
    Uçkan D; Cetin M; Haliloglu M; Ciftçi AO; Tuncer MA; Tezcan I
    Pediatr Transplant; 2001 Oct; 5(5):370-3. PubMed ID: 11560758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significant and persistent improvement of thrombocytopenia after splenectomy in an adult with the Wiskott-Aldrich Syndrome and intra-cerebral bleeding.
    Gaspoz JM; Waldvogel F; Cornu P; Gugler E; Dayer JM
    Am J Hematol; 1995 Mar; 48(3):182-5. PubMed ID: 7864026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of allogeneic bone marrow transplantation from an HLA-identical sibling or a matched unrelated donor in the treatment of children with juvenile chronic myeloid leukaemia.
    Locatelli F; Pession A; Comoli P; Bonetti F; Giorgiani G; Zecca M; Taibi RM; Mongini ME; Ambroselli F; de Stefano P; Severi F; Paolucci G
    Br J Haematol; 1996 Jan; 92(1):49-54. PubMed ID: 8562410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome.
    Hacein-Bey Abina S; Gaspar HB; Blondeau J; Caccavelli L; Charrier S; Buckland K; Picard C; Six E; Himoudi N; Gilmour K; McNicol AM; Hara H; Xu-Bayford J; Rivat C; Touzot F; Mavilio F; Lim A; Treluyer JM; Héritier S; Lefrère F; Magalon J; Pengue-Koyi I; Honnet G; Blanche S; Sherman EA; Male F; Berry C; Malani N; Bushman FD; Fischer A; Thrasher AJ; Galy A; Cavazzana M
    JAMA; 2015 Apr; 313(15):1550-63. PubMed ID: 25898053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of hematopoietic stem cell transplantation in primary immunodeficiency: a report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry.
    Mitchell R; Nivison-Smith I; Anazodo A; Tiedemann K; Shaw P; Teague L; Fraser C; Carter T; Tapp H; Alvaro F; O'Brien TA
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):338-43. PubMed ID: 23228588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct evidence for dissociated megakaryocytic chimaerism in a Wiskott-Aldrich patient successfully allografted.
    Brunel V; Mozziconacci MJ; Sainty D; Faucher C; Arnoulet C; Simonetti J; Maraninchi D; Blaise D; Lafage-Pochitaloff M
    Br J Haematol; 1995 Jun; 90(2):336-40. PubMed ID: 7794753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.